4H-naphth[2,3-b][1,4]oxazin-3-one | 110973-71-2

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并恶嗪类
• 英文名称: 4H-naphth[2,3-b][1,4]oxazin-3-one
• 英文别名: 4H-Naphth[2,3-b][1,4]oxazin-3-on；4H-naphtho-[2,3-b]-2H-1,4-oxazin-3-one；4H-benzo[g][1,4]benzoxazin-3-one
• CAS: 110973-71-2
• 化学式: C₁₂H₉NO₂
• 分子量: 199.209
• InChiKey: NYKPHNWAHJEJDQ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.1
• 重原子数：
  15
• 可旋转键数：
  0
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.08
• 拓扑面积：
  38.3
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为产物：
  描述：

  1-chloroacetyl-1H-naphtho[2,3-d][1,2,3]triazole 在 三氯化铝 、 硝基苯 作用下， 生成 4H-naphth[2,3-b][1,4]oxazin-3-one
  参考文献：
  名称：

  Fries; Walter; Schilling, Justus Liebigs Annalen der Chemie, 1935, vol. 516, p. 248,262

  摘要：

  DOI：

文献信息

• OPTICALLY ACTIVE DINICKEL COMPLEX AND METHOD FOR PRODUCING OPTICALLY ACTIVE AMINE USING THE OPTICALLY ACTIVE DINICKEL COMPLEX AS CATALYST
  申请人：Shibasaki Masakatsu

  公开号：US20100298559A1

  公开（公告）日：2010-11-25

  There is provided a novel optically active dinickel complex and/or a production method of an optically active amine by an asymmetric Mannich reaction using the dinickel complex as a catalyst. An optically active dinickel complex of Formula (I) or Formula (I′): [where R 0 , R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , and R 7 are each independently a hydrogen atom, a halogen atom, a C 1-10 alkyl group or a C 1-10 alkoxy group, etc., R 2 and R 3 together form, together with a benzene ring bonded to them, a naphthalene ring, etc. A novel production method of an optically active amine by an asymmetric Mannich reaction using the dinickel complex as a catalyst.

  提供了一种新型光学活性二镍配合物和/或使用该二镍配合物作为催化剂进行不对称Mannich反应制备光学活性胺的生产方法。公式（I）或公式（I′）的光学活性二镍配合物：[其中R0、R1、R2、R3、R4、R5、R6和R7分别独立地是氢原子、卤素原子、C1-10烷基或C1-10烷氧基等，R2和R3连同与它们结合的苯环形成萘环等。使用该二镍配合物作为催化剂，通过不对称Mannich反应制备光学活性胺的新型生产方法。
• HETEROCYCLIC COMPOUNDS AND EXPANSION AGENTS FOR HEMATOPOIETIC STEM CELLS
  申请人：Nishino Taito

  公开号：US20120128640A1

  公开（公告）日：2012-05-24

  An expansion agent for hematopoietic stem cells and/or hematopoietic progenitor cells useful for improvement in the efficiency of gene transfer into hematopoietic stem cells for gene therapy useful for treatment of various disorders is provided. An expansion agent for hematopoietic stem cells and/or hematopoietic progenitor cells containing a compound represented by the formula (I) (wherein X, Y, Z, Ar 1 , R 1 , R 2 , R 3 , R 4 , R 5 , R6 and R 7 are as defined in the description), a tautomer, prodrug or pharmaceutically acceptable salt of the compound or a solvate thereof, which can expand hematopoietic stem cells and/or hematopoietic progenitor cells.

  提供一种用于改善基因治疗中将基因转移至造血干细胞以治疗各种疾病的血液干细胞和/或造血祖细胞扩张剂。该扩张剂包含由式(I)表示的化合物（其中X、Y、Z、Ar1、R1、R2、R3、R4、R5、R6和R7如描述中所定义）、该化合物的互变异构体、前药或药学上可接受的盐或其溶剂，能够扩张血液干细胞和/或造血祖细胞。
• AMIDE COMPOUND AND THROMBOPOIETIN RECEPTOR ACTIVATOR
  申请人：Miyaji Katsuaki

  公开号：US20090131659A1

  公开（公告）日：2009-05-21

  The present invention provides compounds useful for prevention, treatment or alleviation of diseases against which activation of the thrombopoietin receptor is effective. A compound represented by the formula (1): wherein A, B, R 1 , L 1 , R 2 , L 2 , L 3 , Y, L 4 , R 3 and X are the same as defined in the description, a tautomer, prodrug or pharmaceutically acceptable salt of the compound or a solvate thereof.

  本发明提供了化合物，用于预防、治疗或缓解激活血小板生成素受体对其有效的疾病。其中一种化合物的表示式为（1）：其中A、B、R1、L1、R2、L2、L3、Y、L4、R3和X的定义与描述中相同，以及该化合物的互变异构体、前药或药物可接受的盐或其溶剂化物。
• METHOD FOR AMPLIFICATION OF HEMATOPOIETIC STEM CELL USING HETEROCYCLIC COMPOUND
  申请人：Nissan Chemical Industries, Ltd.

  公开号：EP2228435A1

  公开（公告）日：2010-09-15

  An object of the present invention is to expand CD34+ cells ex vivo efficiently in a short term using a biologically safe and inexpensively obtainable low molecular weight compound. A still another object of the present invention is to provide an expansion agent for CD34+ cells useful for treatment of various hematopoietic disorders caused by dysfunctional hematopoietic stem cells and/or hematopoietic progenitor cells. A method for expanding CD34+ cells, which comprises culturing CD34+ cells ex vivo in the presence of a compound represented by the formula (I) (wherein A, B, L1, L2, L3, L4, R1, R2, R3, X and Y are defined in the description), a tautomer or pharmaceutically acceptable salt of the compound or a solvate thereof.

  本发明的一个目的是利用一种生物安全且廉价的低分子量化合物，在短期内有效地扩增体内外的CD34+细胞。本发明的另一个目的是提供一种CD34+细胞扩增剂，用于治疗由造血干细胞和/或造血祖细胞功能障碍引起的各种造血疾病。 一种扩增CD34+细胞的方法，它包括在存在由式（I）代表的化合物（其中A、B、L1、L2、L3、L4、R1、R2、R3、X和Y在描述中定义）、该化合物的同系物或药学上可接受的盐或其溶液的情况下，体外培养CD34+细胞。
• 952. Synthesis of plant-growth regulators. Part V. (3-substituted 2-naphthyloxy)-n-alkanecarboxylic acids
  作者：D. Woodcock、B. L. Davies

  DOI：10.1039/jr9580004723

  日期：——